{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:48Z","timestamp":1791895608210,"version":"4.3.4"},"reference-count":57,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Multidisciplinary investigations into the pathogenesis of acne have significantly progressed over the past three years. Studies of the etiology of acne from the perspectives, for example, of sebaceous gland biology, sebum, genetics, keratinization, differentiation, hair cycles, immunology, bacteriology, and wound healing have elucidated its pathogenesis. This has led to the development of new therapies and paved the way for advanced studies that will enable the further evolution of acne treatment.<\/ns4:p>","DOI":"10.12688\/f1000research.25588.1","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T14:05:31Z","timestamp":1596031531000},"page":"792","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Recent advances in understanding and managing acne"],"prefix":"10.12688","volume":"9","author":[{"given":"Ichiro","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"821-32","DOI":"10.1111\/j.1600-0625.2009.00890.x","article-title":"New developments in our understanding of acne pathogenesis and treatment.","volume":"18","author":"I Kurokawa","year":"2009","journal-title":"Exp Dermatol."},{"key":"ref-2","article-title":"Acne & Rosacea.","author":"G Plewig","year":"2005"},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1084-91","DOI":"10.1046\/j.1365-2133.2000.03531.x","article-title":"Comedogenesis: Some new aetiological, clinical and therapeutic strategies.","volume":"142","author":"W Cunliffe","year":"2000","journal-title":"Br J Dermatol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"319-34","DOI":"10.1007\/s11154-016-9389-5","article-title":"Beyond acne: Current aspects of sebaceous gland biology and function.","volume":"17","author":"C Zouboulis","year":"2016","journal-title":"Rev Endocr Metab Disord."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"105-11","DOI":"10.1159\/000382031","article-title":"Strategic Targets in Acne: The Comedone Switch in Question.","volume":"231","author":"J Saurat","year":"2015","journal-title":"Dermatology."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"64-7","DOI":"10.4161\/derm.1.2.8486","article-title":"Differentiation of the sebaceous gland.","volume":"1","author":"C Niemann","year":"2009","journal-title":"Dermatoendocrinol."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"677-90","DOI":"10.1111\/bjd.17981","article-title":"Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis.","volume":"181","author":"R Clayton","year":"2019","journal-title":"Br J Dermatol."},{"key":"ref-8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69375-8_16","article-title":"Acne and inflammation.","author":"C Zouboulis","year":"2014"},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"96-106","DOI":"10.1016\/j.bcp.2017.04.030","article-title":"Pharmacological PPAR\u03b3 modulation regulates sebogenesis and inflammation in SZ95 human sebocytes.","volume":"138","author":"A Mastrofrancesco","year":"2017","journal-title":"Biochem Pharmacol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/cells8080895","article-title":"Therapeutic Targeting of the IGF Axis.","volume":"8","author":"E Osher","year":"2019","journal-title":"Cells."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"179-88","DOI":"10.1016\/j.jdermsci.2011.11.005","article-title":"TNF-\u03b1 increases lipogenesis via JNK and PI3K\/Akt pathways in SZ95 human sebocytes.","volume":"65","author":"J Choi","year":"2012","journal-title":"J Dermatol Sci."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"13-9","DOI":"10.1111\/bjd.13634","article-title":"What's new in the physiopathology of acne?","volume":"172 Suppl 1","author":"D Suh","year":"2015","journal-title":"Br J Dermatol."},{"key":"ref-13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69375-8_14","article-title":"Acne and Genetics.","author":"B Melnik","year":"2014"},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"665-76","DOI":"10.1111\/bjd.17721","article-title":"What does acne genetics teach us about disease pathogenesis?","volume":"181","author":"J Common","year":"2019","journal-title":"Br J Dermatol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"247-56","DOI":"10.1111\/j.1365-2133.1996.tb07609.x","article-title":"Keratin expression in pilosebaceous epithelia in truncal skin of acne patients.","volume":"134","author":"B Hughes","year":"1996","journal-title":"Br J Dermatol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"566-71","DOI":"10.1111\/1523-1747.ep12477026","article-title":"Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin.","volume":"91","author":"I Kurokawa","year":"1988","journal-title":"J Invest Dermatol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"176-82","DOI":"10.1111\/1523-1747.ep12329907","article-title":"Modeling Acne in Vitro.","volume":"106","author":"R Guy","year":"1996","journal-title":"J Invest Dermatol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"405-29","DOI":"10.1038\/jid.1956.115","article-title":"Keratinization of the duct of the sebaceous gland and growth cycle of the hair follicle in the histogenesis of acne in human skin.","volume":"27","author":"E van Scott","year":"1956","journal-title":"J Invest Dermatol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"357-64","DOI":"10.1111\/jdv.15926","article-title":"Microcomedones in non-lesional acne prone skin New orientations on comedogenesis and its prevention.","volume":"34","author":"F Fontao","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"217-28","DOI":"10.1111\/j.1600-0625.2009.01006.x","article-title":"Expression of keratins in cutaneous epithelial tumors and related disorders--distribution and clinical significance.","volume":"20","author":"I Kurokawa","year":"2011","journal-title":"Exp Dermatol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"4870-80","DOI":"10.1242\/dev.101725","article-title":"Keratin 79 identifies a novel population of migratory epithelial cells that initiates hair canal morphogenesis and regeneration.","volume":"140","author":"N Veniaminova","year":"2013","journal-title":"Development."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"193-8","DOI":"10.1159\/000087011","article-title":"Review of the innate immune response in acne vulgaris: Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.","volume":"211","author":"J Kim","year":"2005","journal-title":"Dermatology."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"20-7","DOI":"10.1046\/j.1523-1747.2003.12321.x","article-title":"Inflammatory events are involved in acne lesion initiation.","volume":"121","author":"A Jeremy","year":"2003","journal-title":"J Invest Dermatol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1226-8","DOI":"10.1046\/j.1523-1747.2003.12550_6.x","article-title":"Propionibacterium acnes-Reactive T Helper-1 Cells in the Skin of Patients with Acne Vulgaris.","volume":"121","author":"P Mouser","year":"2003","journal-title":"J Invest Dermatol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"47-52","DOI":"10.1016\/j.jdermsci.2009.02.015","article-title":"Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: Host response but not bacterial species is the determinant factor of the disease.","volume":"55","author":"H Sugisaki","year":"2009","journal-title":"J Dermatol Sci."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"316-24","DOI":"10.1016\/j.jid.2017.07.842","article-title":"Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin.","volume":"138","author":"G Agak","year":"2018","journal-title":"J Invest Dermatol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"2355-64","DOI":"10.1016\/j.jid.2018.05.032","article-title":"The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.","volume":"138","author":"Y Wang","year":"2018","journal-title":"J Invest Dermatol."},{"key":"ref-28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.12.026","article-title":"Identification of a Human Skin Commensal Bacterium that Selectively Kills Cutibacterium acnes.","author":"A O\u2019Neill","year":"2020","journal-title":"J Invest Dermatol."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"1070-2","DOI":"10.1111\/j.1600-0625.2009.00891.x","article-title":"Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin.","volume":"18","author":"P Lyte","year":"2009","journal-title":"Exp Dermatol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"383-6","DOI":"10.1111\/ced.12540","article-title":"Acne conglobata and adalimumab: Use of tumour necrosis factor-\u03b1 antagonists in treatment-resistant acne conglobata, and review of the literature.","volume":"40","author":"Z Yiu","year":"2015","journal-title":"Clin Exp Dermatol."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"619-44","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa.","volume":"29","author":"C Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"802-7","DOI":"10.1111\/1346-8138.14998","article-title":"Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.","volume":"46","author":"T Takahashi","year":"2019","journal-title":"J Dermatol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"80-8","DOI":"10.1016\/j.jaad.2018.06.046","article-title":"Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial.","volume":"80","author":"M Vossen ARJV, van Doorn","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"2723-31","DOI":"10.1038\/jid.2015.277","article-title":"Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response.","volume":"135","author":"M Qin","year":"2015","journal-title":"J Invest Dermatol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"8-12","DOI":"10.1111\/jdv.14374","article-title":"What is new in the pathophysiology of acne, an overview.","volume":"31 Suppl 5","author":"B Dr\u00e9no","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"109-17","DOI":"10.1067\/mjd.2001.113451","article-title":"Acne scarring: A classification system and review of treatment options.","volume":"45","author":"C Jacob","year":"2001","journal-title":"J Am Acad Dermatol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"401-5","DOI":"10.1111\/1346-8138.13634","article-title":"Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non-inflamed atrophic scars in acne vulgaris.","volume":"44","author":"I Kurokawa","year":"2017","journal-title":"J Dermatol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"72-81","DOI":"10.1111\/j.1365-2133.2004.05749.x","article-title":"Inflammation in acne scarring: A comparison of the responses in lesions from patients prone and not prone to scar.","volume":"150","author":"D Holland","year":"2004","journal-title":"Br J Dermatol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"906-17","DOI":"10.1111\/bjd.16680","article-title":"Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands.","volume":"179","author":"I Carlavan","year":"2018","journal-title":"Br J Dermatol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"572-84","DOI":"10.1111\/iwj.12484","article-title":"Vitamin C promotes wound healing through novel pleiotropic mechanisms.","volume":"13","author":"B Mohammed","year":"2016","journal-title":"Int Wound J."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"e347-e348","DOI":"10.1111\/1346-8138.14930","article-title":"Split-face comparative clinical trial using glyceryl-octyl-ascorbic acid\/ascorbyl 2-phosphate 6-palmitate\/DL-\u03b1-tocopherol phosphate complex treatment for postinflammatory hyperpigmentation, postinflammatory erythema and atrophic scar in acne vulgaris.","volume":"46","author":"I Kurokawa","year":"2019","journal-title":"J Dermatol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"28-32","DOI":"10.4236\/jcdsa.2020.101004","article-title":"Effect of a Cosmetic Use with 2% Isostearyl-L-Ascorbic Acid Gel for Postinflammatory Hyperpigmentation and Postinflammatory Erythema in Acne Vulgaris.","volume":"10","author":"I Kurokawa","year":"2020","journal-title":"JCDSA."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"e238-e239","DOI":"10.1111\/1346-8138.14292","article-title":"Non-surgical treatment with basic fibroblast growth factor for atrophic scars in acne vulgaris.","volume":"45","author":"I Kurokawa","year":"2018","journal-title":"J Dermatol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"415-6","DOI":"10.1111\/j.1365-2133.2007.08047.x","article-title":"Filaggrin expression and the pathogenesis of epidermal cysts.","volume":"157","author":"I Kurokawa","year":"2007","journal-title":"Br J Dermatol."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"329-33","DOI":"10.1056\/NEJM197902153000701","article-title":"Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid.","volume":"300","author":"G Peck","year":"1979","journal-title":"N Engl J Med."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4172\/2161-0509.1000215","article-title":"Successful adjuvant alternative treatment with Saireito (Japanese herbal medicine) for nodulocystic acne.","volume":"7","author":"I Kurokawa","year":"2017","journal-title":"J Nutr Disorders Ther."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"e299-e301","DOI":"10.1111\/1346-8138.14832","article-title":"Perifolliculitis capitis abscedens et suffodiens successfully treated with Saireito.","volume":"46","author":"I Kurokawa","year":"2019","journal-title":"J Dermatol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2375-4273.1000160","article-title":"Comprehensive Multiplexed Therapy for Severe Nodulocystic Acne in Puberty. Comprehensive multiplex therapy for cystic acne","volume":"4","author":"I Kurokawa","year":"2016"},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"198-210","DOI":"10.1016\/s0923-1811(01)00161-x","article-title":"Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1\/Th2 cytokines balance of the autoimmunity of MRL\/lpr mice.","volume":"28","author":"T Ito","year":"2002","journal-title":"J Dermatol Sci."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"898-935","DOI":"10.1111\/1346-8138.14355","article-title":"Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017.","volume":"45","author":"N Hayashi","year":"2018","journal-title":"J Dermatol."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"853846","DOI":"10.1155\/2015\/853846","article-title":"Inhibition of Rat 5\u03b1-Reductase Activity and Testosterone-Induced Sebum Synthesis in Hamster Sebocytes by an Extract of Quercus acutissima Cortex.","volume":"2015","author":"J Koseki","year":"2015","journal-title":"Evid Based Complement Alternat Med."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"4-9","DOI":"10.1111\/j.1346-8138.1995.tb03332.x","article-title":"The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes.","volume":"22","author":"S Higaki","year":"1995","journal-title":"J Dermatol."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"255-65","DOI":"10.1177\/030006059702500503","article-title":"Effect of keigai-rengyo-to, a Japanese kampo medicine, on neutrophil functions: A possible mechanism of action of keigai-rengyo-to in acne.","volume":"25","author":"H Akamatsu","year":"1997","journal-title":"J Int Med Res."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/ijms18030606","article-title":"Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.","volume":"18","author":"R Ogawa","year":"2017","journal-title":"Int J Mol Sci."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"298-306","DOI":"10.4103\/0378-6323.199581","article-title":"Update on etiopathogenesis and treatment of Acne.","volume":"83","author":"Y Bhat","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"ref-56","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16252","article-title":"Sebocyte Differentiation as a New Target for Acne Therapy: An in Vivo Experience.","author":"M Ottaviani","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"386-91","DOI":"10.1111\/exd.12159","article-title":"What is the role of antimicrobial peptides (AMP) in acne vulgaris?","volume":"22","author":"J Harder","year":"2013","journal-title":"Exp Dermatol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-792\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-792\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-792\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T14:05:35Z","timestamp":1596031535000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-792\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":57,"URL":"https:\/\/doi.org\/10.12688\/f1000research.25588.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.28239.r68286","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.28239.r68285","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-792\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.28239.r68285, Dae Hun Suh, Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea, 29 Jul 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-792\/v1#referee-response-68285","order":0,"name":"referee-response-68285","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.28239.r68286, Mauro Picardo, Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy, 29 Jul 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-792\/v1#referee-response-68286","order":1,"name":"referee-response-68286","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}